|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q64793203
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010851.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q64793203
|
|
024
|
|
|
‡a
0000-0002-7083-580X
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q64793203
|
|
100
|
0 |
|
‡a
Verónica Morán
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Verónica Morán
‡c
onderzoeker
‡9
nl
|
|
400
|
0 |
|
‡a
Verónica Morán
‡c
investigador
‡9
es
|
|
670
|
|
|
‡a
Author's Effective dose estimation for oncological and neurological PET/CT procedures
|
|
670
|
|
|
‡a
Author's Impact of the dosimetry approach on the resulting <sup>90</sup>Y radioembolization planned absorbed doses based on <sup>99m</sup>Tc-MAA SPECT-CT: is there agreement between dosimetry methods?
|
|
909
|
|
|
‡a
(orcid) 000000027083580x
‡9
1
|
|
919
|
|
|
‡a
impactofthedosimetryapproachontheresultingsup90supyradioembolizationplannedabsorbeddosesbasedonsup99msuptcmaaspectctisthereagreementbetweendosimetrymethods
‡A
Impact of the dosimetry approach on the resulting <sup>90</sup>Y radioembolization planned absorbed doses based on <sup>99m</sup>Tc-MAA SPECT-CT: is there agreement between dosimetry methods?
‡9
1
|
|
919
|
|
|
‡a
effectivedoseestimationforoncologicalandneurologicalpetctprocedures
‡A
Effective dose estimation for oncological and neurological PET/CT procedures
‡9
1
|
|
996
|
|
|
‡2
LC|nb2018012348
|
|
996
|
|
|
‡2
ISNI|0000000496886431
|
|
996
|
|
|
‡2
LC|nb2009025588
|
|
996
|
|
|
‡2
LC|no2013052744
|
|
996
|
|
|
‡2
BNCHL|10000000000000000291139
|
|
996
|
|
|
‡2
BNCHL|10000000000000000221723
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
